Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 65

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 65
---
 related expenses, from share based payment expenses and other expenses. The decrease was mainly due to lower share based payment
expense recorded in the three months period ended March 31, 2025 compared with the same period in 2024.

<div align='center'>37</div>

General and Administrative Expenses

Successor’s general and administrative
expenses totaled $519 thousand for the three months period ended March 31, 2025, representing an increase of $439 thousand, or 548.7%,
compared to Predecessor’s $80 thousand for the same period. The general and administrative expenses comprise mainly from salaries
and related expenses, share based payment expenses, professional services and other expenses. The increase was primarily attributable
to higher share-based payment expense, Successor’s salaries and related expenses and Successor’s professional services for
such period compared to not significant or no such expenses in the Predecessor for the same period.

Operating Loss

As a result of the foregoing, Successor’s
operating loss totaled $737 thousand for the three months period ended March 31, 2025, representing an increase of $87 thousand, or 13.4%,
compared to Predecessor’s $650 thousand loss for the same period.

Financing income, Net

Successor recognized financing income, net
of $103 thousand for the three months period ended March 31, 2025, representing an increase of $103 thousand, or 100.0%, compared to
Predecessor’s finance income, net of less than $1 thousand for the same period. The increase in finance income, net was primarily
attributable to Successor’s interest income from deposit and higher exchange rate differences between the U.S. dollar and the New
Israeli Shekel.

Net and Comprehensive Loss

As a result of the foregoing, Successor’s
loss totaled $634 thousand for the three months period ended March 31, 2025, representing a decrease of $16 thousand, or 2.5%, compared
to Predecessor’s $650 thousand for the same period.

Successor for the period from July 24, 2024 through December 31, 2024, the Predecessor period from January 1, 2024 through July 23, 2024, and for the year ended December 31, 2023

The following tables present selected financial
data for the Successor period from July 24, 2024 through December 31,